HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enterocolitis

Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.
Also Known As:
Enterocolitides
Networked: 2104 relevant articles (76 outcomes, 170 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Constipation
3. Inflammation (Inflammations)
4. Birth Weight (Birth Weights)
5. Infections

Experts

1. Nowak-Wegrzyn, Anna: 24 articles (10/2021 - 04/2003)
2. Nowak-Węgrzyn, Anna: 21 articles (01/2021 - 05/2011)
3. McGuire, William: 18 articles (01/2022 - 04/2008)
4. Barni, Simona: 17 articles (01/2022 - 07/2013)
5. Cianferoni, Antonella: 17 articles (01/2022 - 12/2009)
6. Mori, Francesca: 14 articles (01/2022 - 06/2014)
7. Caubet, Jean-Christoph: 14 articles (01/2021 - 05/2011)
8. Infante, Sonsoles: 12 articles (11/2022 - 01/2017)
9. Sicherer, Scott H: 12 articles (01/2021 - 04/2003)
10. Ohlsson, Arne: 12 articles (11/2020 - 06/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Enterocolitis:
1. Proteins (Proteins, Gene)FDA Link
2. Adrenal Cortex Hormones (Corticosteroids)IBA
3. Infliximab (Remicade)FDA Link
4. Anti-Bacterial Agents (Antibiotics)IBA
11/01/2020 - "While a consensus for the definition of Hirschsprung associated enterocolitis (HAEC) is lacking, the mainstay of treatment includes rectal irrigations with or without antibiotics. "
01/01/2022 - "This study aimed to investigate the risk of IBD development associated with antibiotic use and enterocolitis in Japan. "
01/01/2021 - "None of the five comparisons found any evidence of a difference when assessing all-cause mortality, serious adverse events, circulatory support, nephrotoxicity, neurological developmental impairment, or necrotising enterocolitis; however, none of the trials were near an information size that could contribute significantly to the evidence of the comparative benefits and risks of any particular antibiotic regimen. "
01/01/2021 - "None of the five comparisons found any evidence of a difference when assessing all-cause mortality, serious adverse events, circulatory support, nephrotoxicity, neurological developmental impairment, or necrotising enterocolitis; however, none of the trials were near an information size that could contribute significantly to the evidence of the comparative benefits and risks of any particular antibiotic regimen. "
05/09/2014 - "Although it has received a degree of notoriety as a cause for antibiotic-associated enterocolitis (AAE), the role of methicillin resistant Staphylococcus aureus (MRSA) in the pathogenesis of this disease remains enigmatic despite a multitude of efforts, and previous studies have failed to conclude whether MRSA can cause AAE. "
5. Immune Checkpoint InhibitorsIBA
6. vedolizumabIBA
7. CytokinesIBA
8. Indomethacin (Indometacin)FDA LinkGeneric
9. Botulinum Toxins (Botulinum Toxin)IBA
10. GlucocorticoidsIBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Injections
4. Enteral Nutrition (Feeding, Tube)
5. Length of Stay